{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:34Z","timestamp":1783075894666,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.eplepsyres.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T19:02:33Z","timestamp":1496516553000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: A meta-analysis"],"prefix":"10.1016","volume":"135","author":[{"given":"Qianyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","article-title":"HLA-B locus in Caucasian patients with carbamazepine hypersensitivity","volume":"7","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/epi.12564","article-title":"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions","volume":"55","author":"Amstutz","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jnci\/81.2.107","article-title":"Publication bias and dissemination of clinical research","volume":"81","author":"Begg","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2217\/pgs.14.65","article-title":"Pharmacogenetics of antiepileptic drug-induced hypersensitivity","volume":"15","author":"Bloch","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepineinducedtoxic effects and HLA-B*1502screening in Taiwan","volume":"364","author":"Chen","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0035","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","article-title":"Human leukocyte antigens and drug hypersensitivity","volume":"7","author":"Chung","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0045","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1684\/ejd.2010.1150","article-title":"Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon?","volume":"21","author":"Cozzani","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0060","series-title":"Information for Healthcare Professionals: Dangerous or Even Fatal Skin Reactions: Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and Generics)","author":"Food and Drug Administration Alert","year":"2013"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0000000000000021","article-title":"HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis","volume":"24","author":"Grover","year":"2014","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/clpt.2010.357","article-title":"The genetics of antiepileptic drug-induced skin reactions","volume":"89","author":"Hakimian","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0075","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S1734-1140(13)71483-X","article-title":"Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in Han individuals of northeastern China","volume":"65","author":"He","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","article-title":"Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations","volume":"73","author":"Hsiao","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0090","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0095","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0105","first-page":"16","article-title":"Association between HLA-B*15:02 allele and antiepileptic drug-induced severe cutaneous reactions in Hong Kong Chinese: a population-based study","volume":"20","author":"Kwan","year":"2014","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1034\/j.1399-0039.2000.560505.x","article-title":"HLA-B*15 diversity in the Korean population","volume":"56","author":"Lee","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","article-title":"Forest plots: trying to see the wood and the trees","volume":"322","author":"Lewis","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson syndrome.: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0125","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0130","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5415\/apallergy.2015.5.2.68","article-title":"HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese","volume":"5","author":"Nguyen","year":"2015","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1346-8138.2011.01457.x","article-title":"HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population","volume":"39","author":"Niihara","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.0014-3820.2005.tb01004.x","article-title":"The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis","volume":"59","author":"Rosenberg","year":"2005","journal-title":"Evolution"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0155","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0160","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","article-title":"Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?","volume":"111","author":"Shi","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(24)01501-1","article-title":"Cutaneous drug reactions","volume":"53","author":"Svensson","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0175","first-page":"139","article-title":"Report of the japanese central bone marrow data center","author":"Tanaka","year":"1996","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0180","first-page":"1025","article-title":"Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"49","author":"Tangamornsuksan","year":"2013","journal-title":"AMA Dermatol."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0185","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2014.05.025","article-title":"Genetic predictors of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population","volume":"37","author":"Wang","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0195","first-page":"727","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","volume":"18","author":"Wells","year":"2000","journal-title":"Appl. Eng. Agric."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0200","first-page":"CD005451","article-title":"Carbamazepine for acute and chronic pain in adults","volume":"19","author":"Wiffen","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/jidsymp.2015.6","article-title":"Research on susceptible genes and immunological pathogenesis of cutaneous adverse drug reactions in chinese hans","volume":"17","author":"Yang","year":"2015","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0210","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/clpt.2012.189","article-title":"HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review","volume":"92","author":"Yip","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2017.05.015_bib0215","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/all.12008","article-title":"Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA","volume":"67","author":"Yun","year":"2012","journal-title":"Allergy"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116303114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116303114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:37:38Z","timestamp":1760276258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116303114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":43,"alternative-id":["S0920121116303114"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.05.015","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}